Inconsistent Verdict Results In New Trial, Vacating Of $140M AndroGel Verdict
CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on July 5 vacated a $140.14 million verdict in the second AndroGel bellwether trial, finding the jury’s inconsistent...To view the full article, register now.
Already a subscriber? Click here to view full article